Continuous flow chemistry is emerging as a transformative strategy for pharmaceutical synthesis, providing a sustainable and efficient alternative to conventional batch processes. Flow systems offer precise control over key reaction variables temperature, pressure, and residence time enhancing product consistency, accelerating reaction rates, and reducing waste in line with Green Chemistry principles. Recent applications include the synthesis of active pharmaceutical ingredients (APIs) such as flibanserin, celecoxib, valsartan, mesalazine, and other complex heterocycles, achieving higher yields, selectivity, and scalability. Multicomponent reactions in flow further enable the rapid construction of drug like molecules while minimizing step count and environmental impact. Although challenges remain in equipment cost and scale up, continuous flow technology represents a pivotal step toward safer, faster, and more sustainable pharmaceutical manufacturing.